Malaria drug could help fight dangerous virus in transplant patients
Disease control
Recruiting now
This study tests whether adding the malaria drug artesunate to standard antiviral treatment can better control cytomegalovirus (CMV) infection in people who have received a solid organ transplant (kidney, lung, heart, or liver). About 90 adult participants will receive either a l…
Phase: PHASE2 • Sponsor: Amivas Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC